We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+25.19%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$4.52B
AUM Growth
+$762M
Cap. Flow
+$251M
Cap. Flow %
5.54%
Top 10 Hldgs %
32.69%
Holding
126
New
33
Increased
18
Reduced
34
Closed
36

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$104M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$86M
3
AGN
Allergan plc
AGN
+$83.3M
4
PFE icon
Pfizer
PFE
+$80.2M
5
PBYI icon
Puma Biotechnology
PBYI
+$79.5M

Top Sells

Rank Stock Value
1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$145M
2
ABT icon
Abbott
ABT
+$82.8M
3
GDDY icon
GoDaddy
GDDY
+$79.9M
4
AERI
Aerie Pharmaceuticals
AERI
+$68.4M
5
BLK icon
Blackrock
BLK
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 54.61%
2 Technology 11.18%
3 Communication Services 3.96%
4 Consumer Discretionary 3.1%
5 Financials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GDOT icon
101
Green Dot
GDOT
$754M
– –
-127,577
Closed -$10.1M
KURA icon
102
Kura Oncology
KURA
$816M
– –
-1,143,917
Closed -$16.1M
NCNA
103
NuCana
NCNA
$5.62M
– –
-89
Closed -$6.49M
NOW icon
104
ServiceNow
NOW
$118B
– –
-269,955
Closed -$9.61M
OEF icon
105
CALL
iShares S&P 100 ETF
OEF
$20.1B
– –
-4,470,900
Closed -$175M
RAMP icon
106
LiveRamp
RAMP
$2.3B
– –
-236,405
Closed -$9.13M
RCUS icon
107
Arcus Biosciences
RCUS
$3.47B
– –
-220,976
Closed -$2.38M
SLDB icon
108
Solid Biosciences
SLDB
$790M
– –
-89,005
Closed -$35.8M
STIM icon
109
Neuronetics
STIM
$150M
– –
-22,937
Closed -$444K
STNE icon
110
StoneCo
STNE
$2.76B
– –
-86,453
Closed -$1.59M
ZS icon
111
Zscaler
ZS
$25B
– –
-46,814
Closed -$1.84M
TECX
112
Tectonic Therapeutic
TECX
$527M
– –
-20,118
Closed -$4.02M
MRNS
113
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-131,166
Closed -$1.51M
VRAY
114
DELISTED
ViewRay, Inc.
VRAY
– –
-2,114,316
Closed -$12.8M
ACOR
115
CALL
DELISTED
Acorda Therapeutics
ACOR
– –
-14,492
Closed -$27.1M
ACOR
116
DELISTED
Acorda Therapeutics
ACOR
– –
-9,239
Closed -$17.3M
AERI
117
DELISTED
Aerie Pharmaceuticals
AERI
– –
-1,893,935
Closed -$68.4M
PLAN
118
DELISTED
Anaplan, Inc.
PLAN
– –
-33,587
Closed -$891K
CBLK
119
DELISTED
Carbon Black, Inc. Common Stock
CBLK
– –
-231,286
Closed -$3.1M
CMTA
120
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
– –
-849,904
Closed -$9.99M
ATVI
121
DELISTED
Activision Blizzard
ATVI
– –
-4,226
Closed -$197K
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q1 2019 Portfolio in Review

As of Q1 2019, PFM Health Sciences held 126 positions worth $4.52B, up 20% from $3.76B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

PFM Health Sciences deployed $251M of net new capital in Q1 2019, opening 33 new positions and adding to 18 existing holdings. Its largest new stake was Stryker: 579,444 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 51% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Spark Therapeutics, Inc. Common Stock, an estimated $145M trimmed.

  • PFM Health Sciences's largest Q1 2019 buy was Stryker: 579,444 shares worth $114M.
  • PFM Health Sciences added most to Pfizer in Q1 2019, an estimated $80.2M increase.
  • PFM Health Sciences's biggest Q1 2019 reduction was Spark Therapeutics, Inc. Common Stock, cutting an estimated $145M.
  • PFM Health Sciences fully exited Abbott in Q1 2019, selling an estimated $82.8M.
  • PFM Health Sciences's ten largest holdings make up 33% of its $4.52B portfolio in Q1 2019.
  • PFM Health Sciences opened 33 new positions and closed 36 in Q1 2019.
  • PFM Health Sciences's portfolio value rose 20% quarter-over-quarter to $4.52B.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.